Platelet pharmacogenomics
- 1 June 2010
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 8 (6) , 1147-1158
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel TherapyJAMA, 2009
- Clinically Available Pharmacogenomics TestsClinical Pharmacology & Therapeutics, 2009
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- Genetic Determinants of Response to Clopidogrel and Cardiovascular EventsNew England Journal of Medicine, 2009
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyThe Lancet, 2009
- Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary interventionEuropean Heart Journal, 2008
- CYP2C19 and Nongenetic Factors Predict Poor Responsiveness to Clopidogrel Loading dose after Coronary Stent ImplantationPharmacogenomics, 2008
- Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery diseaseBMC Medical Genetics, 2007
- Effect of genetic variations in platelet glycoproteins Ibα and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapyBlood, 2006
- A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressantsClinical Pharmacology & Therapeutics, 2006